from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0827c/kmtR

LFCtreatmentdescriptionclass of inhibitor

-0.423

Amikacinug/mL Amikacintranslation

0.275

Cap5-10ug/mL Capreomycintranslation

1.310

Rox10-50 ug/mL Roxithromycintranslation

0.203

SM2-5 ug/mL Streptomycintranslation

2.012

Tet5-10 ug/mL Tetracyclinetranslation

-0.264

Rif0.2-5ug/mL Rifampicintranscription

-0.372

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.582

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.336

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.371

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.255

Clofazimine10-13 ug/mL Clofaziminerespiration

0.651

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.149

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.092

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.165

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.259

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.445

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.744

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.336

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.139

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.631

KCN5-20 ug/mL Potassium cyaniderespiration

0.046

NaN30.2-2 mM Sodium aziderespiration

0.174

Nigericin50 uM Nigericinrespiration

-0.318

TRC10-150 ug/mL Triclosanrespiration

-0.452

TRZ10-25 ug/mL Thioridazinerespiration

1.363

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.266

menadione6-10 ug/mL Menadionerespiration

-1.036

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.408

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.295

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.514

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.094

NRP_1Non-replicating persistence stage 1dosRassociated

-0.717

Amp0.2mg/mL AmpicillincellWall

-0.263

Cephalexin20-100 ug/mL CephalexincellWall

-0.755

Cerulenin0.32-5 ug/mL CerulenincellWall

0.332

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.509

EMB10-20 ug/mL EthambutolcellWall

-0.164

Eta12-40 ug/mL EthionamidecellWall

-0.228

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.724

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.049

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.251

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.579

BZA0.12 mg/mL BenzamidearomaticAmides

0.609

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.511

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.447

H2O24 mM hydrogen peroxideDNAdamaging

-0.277

Levo10 ug/mL LevofloxacinDNAdamaging

-0.292

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.940

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.273

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.304

UVUV-irradiationDNAdamaging

0.657

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.238

Antimycin12.5-50 ug/mL Antimycin A?

-0.832

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.739

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.157

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.470

PA8240.2-2 ug/mL PA-824?

0.560

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.043

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.087

Verapamil50 uM Verapamil?

-1.162

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.247

methoxatin10-20 ug/mL Methoxatin?